Improving outcomes in colorectal cancer (CSG5)
This guidance has been updated and replaced by NICE guideline NG151.
Search results
227 results
-
-
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
In development [GID-HST10004] Expected publication date: TBC
-
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
In development [GID-HST10007] Expected publication date: TBC
-
Xpert MTB/RIF assay for the detection of active pulmonary tuberculosis and multi-drug resistant tuberculosis
In development [GID-DT9] Expected publication date: TBC
-
KRAS mutation testing of tumours in adults with metastatic colorectal cancer (discontinued)
In development [GID-DT14] Expected publication date: TBC
-
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia (DG2)
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
-
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index (DG17)
This guideline has been updated and replaced by NICE guideline NG131.
-
Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat (DG10)
This guidance has been updated and replaced by NICE diagnostics guidance 34.
-
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System (DG4)
This guidance has been updated and replaced by NICE diagnostics guidance 32.
-
Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays) (DG15)
This guidance has been updated and replaced by NICE diagnostics guidance 40.
-
Multiple myeloma and related disorders - Freelite assays (and alternative technologies identified during scoping) for diagnosis in primary care
In development [GID-DT28] Expected publication date: TBC
-
Four commonly used methods to increase physical activity (PH2)
This guideline covered four common methods used to increase the population's physical activity levels: brief interventions in primary care, exercise referral schemes, pedometers and community-based walking and cycling programmes. It has been updated and replaced by the following NICE guidelines:
- Walking and cycling (2012) PH41
- Physical activity: brief advice for adults in primary care (2013) PH44
- Exercise referral schemes to promote physical activity (2014) PH54
-
HIV testing: increasing uptake in black Africans (PH33)
This guidance has been updated and replaced by NICE guideline NG60.
-
Workplace health for employees with disabilities and long-term conditions
In development [GID-PHG58] Expected publication date: TBC
-
Smoking: brief interventions and referrals (PH1)
This guidance has been updated and replaced by NICE guideline NG92.
-
Workplace health - older employees
In development [GID-PHG59] Expected publication date: 24 March 2016
-
Personal, social, health and economic education focusing on sex and relationships and alcohol education
In development [GID-PHG0] Expected publication date: TBC
-
Housing: planning to improve health and wellbeing
In development [GID-NG10053] Expected publication date: TBC
-
Physical activity and the environment (PH8)
This guideline has been updated and replaced by NICE guideline NG90.
-
Community engagement (PH9)
This guidance has been updated and replaced by NICE guideline NG44.
-
Needle and syringe programmes (PH18)
This guideline has been updated and replaced by NICE guideline PH52.
-
Workplace health: long-term sickness absence and incapacity to work (PH19)
This guideline has been updated and replaced by NICE guideline NG146.
-
Alcohol: school-based interventions (PH7)
This guideline has been updated and replaced by NICE guideline NG135.
-
Stop smoking services (PH10)
This guideline has been updated and replaced by NICE guideline NG92.
-
HIV testing: increasing uptake in men who have sex with men (PH34)
This guideline has been updated and replaced by NICE guideline NG60.
-
Tuberculosis: identification and management in under-served groups (PH37)
This guideline has been updated and replaced by NICE guideline NG33.
-
Substance misuse interventions for vulnerable under 25s (PH4)
This guidance has been updated and replaced by NICE guideline NG64.